Below are brief introductions to measles disease and the measles vaccine with links to more information. Scroll down for a list of QUICK FACTS that provide a summary overview of key facts for the disease and the vaccine.
Measles (rubeola) is a highly contagious respiratory disease spread by coughing, sneezing, or simply being in close contact with an infected individual. The disease can be spread even when the rash is not visible.1 Measles tends to be more severe in children under five and adults over 20.2 Initial measles symptoms include fever, cough, runny nose, red irritated eyes, and sore throat with tiny white spots on the cheeks inside the mouth (Koplik spots). These symptoms generally last 2-4 days and are followed by the signature itchy red rash on the body around the fourth or fifth day.
Most measles cases in the U.S. resolve without complication, though serious complications can occur.3 According to the U.S. Centers for Disease Control (CDC), Americans born before 1957 have naturally-acquired immunity to measles through past exposure to the illness.4 Infants born to mothers with naturally-acquired antibodies to measles benefit from passive maternal immunity. There is also evidence that mothers who have recovered from measles pass short-term measles immunity to their infants by breastfeeding.5
The measles vaccine is a weakened (attenuated) form of the live measles virus. There are three live virus vaccines currently available for use in the U.S.: Merck’s MMRII vaccine containing measles, mumps, and rubella attenuated live viruses;6 Merck’s Proquad (MMRV) vaccine containing measles, mumps, rubella, and varicella attenuated live viruses;7 and GlaxoSmithKline’s PRIORIX containing measles, mumps, and rubella attenuated live viruses.8 The CDC currently recommends that children receive two doses of a measles containing vaccine, with the first dose administered between 12-15 months and the second dose between 4-6 years.9 The CDC also recommends that individuals born after 1957 who have no laboratory evidence of immunity or documentation of vaccination should receive at least one dose of MMR vaccine.10